Research Paper Volume 10, Issue 1 pp 115—130

HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition

Figure 5. Combined value of HOXC6 and serum AFP identify different risks of HCC death and recurrence. The associations of HOXC6/AFP co-expression with Overall survival (log-rank P < 0.001) (A) and Time to recurrence (log-rank P < 0.001) (B) in 164 HCC patients.